adamantane has been researched along with yo-pro 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradshaw, E; Broom, DC; Buck, ME; Coombs, S; Cortright, DN; Ford, KK; Krause, JE; Matchett, M; Matson, DJ; Meade, R; Ochoa, R; Sun, SH; Wustrow, DJ; Yu, W; Yuan, J | 1 |
| Bowyer, SL; Kassiou, M; O'Brien-Brown, J; Reekie, TA; Werry, EL; Wong, ECN | 1 |
2 other study(ies) available for adamantane and yo-pro 1
| Article | Year |
|---|---|
Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation.
Topics: Adamantane; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzamides; Benzoxazoles; Calcium; Disease Models, Animal; Humans; Inflammation; Inhibitory Concentration 50; Pain; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2X7 | 2008 |
Pharmacological evaluation of a novel series of urea, thiourea and guanidine derivatives as P2X
Topics: Adamantane; Adenosine Triphosphate; Benzoxazoles; Cell Line; Fluorescent Dyes; Guanidines; Humans; Molecular Structure; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Quinolinium Compounds; Thiourea; Urea | 2017 |